News Focus
News Focus
icon url

DewDiligence

03/27/14 5:25 PM

#176118 RE: DewDiligence #163077

PTLA starts phase-2 trial of Andexanet Alfa (f/k/a PRT4445) as an antidote to Daiichi Sankyo’s Edoxaban:

http://finance.yahoo.com/news/portola-pharmaceuticals-initiates-phase-2-120000764.html

This trial took a long time to get fired up insofar as PTLA’s collaboration with Daiichi Sankyo was announced 9 months ago (#msg-89410130).